Due to the scarcity of reported anti-mGluR1 encephalitis cases globally, comprehensive multicenter studies incorporating diverse ethnic populations with distinct genetic profiles are imperative to elucidate the full clinical spectrum, immunopathogenic mechanisms, and long-term prognostic outcomes of this autoimmune disorder. The gene discussed is GRM1; the disease is encephalitis.